Core Insights - Amazon is launching prescription drug kiosks at One Medical offices in Los Angeles, aiming to disrupt traditional pharmacy businesses [1][3] - The kiosks, operated by Amazon Pharmacy, dispense prescriptions within minutes of a doctor's visit, addressing the issue of unfilled prescriptions due to extra trips to pharmacies [3][6] - This initiative comes as pharmacy chains like Rite Aid, CVS, and Walgreens face declining drug margins and increased competition from retailers like Amazon and Walmart [3][4] Company Strategy - Amazon has been expanding into the U.S. healthcare industry, acquiring PillPack in 2018 for approximately $750 million and One Medical in 2022 for $3.9 billion [5] - The company restructured its healthcare businesses into six units earlier this year to enhance innovation and speed [6] - The kiosks will initially be available at specific One Medical locations, with plans to expand to more offices and environments where quick access to medication is beneficial [6] Kiosk Operation - Each kiosk can stock hundreds of prescriptions tailored to specific locations, including common medications like antibiotics and blood pressure treatments [2] - Patients must have their prescriptions sent to Amazon Pharmacy for verification before using the kiosk, which includes a final check by a remote pharmacist [7] - The kiosks are designed to complement pharmacists' roles rather than replace them, allowing for video or phone consultations with pharmacists [8]

Core Viewpoint - Medtronic plc has appointed Chad Spooner as the chief financial officer (CFO) of MiniMed, ahead of its planned separation into a standalone public company, effective July 14, 2025 [1][5]. Company Overview - Medtronic is a global leader in healthcare technology, headquartered in Galway, Ireland, with a mission to alleviate pain, restore health, and extend life [8]. - The company employs over 95,000 people across more than 150 countries and addresses 70 health conditions through various technologies and therapies [8]. Leadership Appointment - Chad Spooner brings over 25 years of financial leadership experience in healthcare, consumer, and industrial sectors, previously serving as CFO at BIC and holding senior finance roles at General Electric and other companies [2][4]. - His appointment is seen as crucial for driving transformation and growth as MiniMed prepares for independence [3][4]. MiniMed Separation - Medtronic announced that MiniMed will be the name of the new standalone company, honoring its 40-year legacy in diabetes care [3]. - The separation is expected to be completed within 18 months of the initial announcement, subject to customary conditions and legal requirements [5]. Mission and Vision - MiniMed's mission is to make diabetes management more predictable, enhancing the lives of individuals with diabetes through advanced technology and support [7].